Ovid Therapeutics Inc. Financing Cash Flow
Ovid Therapeutics Inc. (OVID) reported Financing Cash Flow of $110.58 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-13
- Ovid Therapeutics Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $21.60M.
- Ovid Therapeutics Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $88.98M, a 684376.92% increase year-over-year.
- Ovid Therapeutics Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $75.18M.
- Ovid Therapeutics Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $15.00K, a 60.53% decline year-over-year.
- Ovid Therapeutics Inc. net cash provided by (used in) financing activities for fiscal 2025 was $75.21M, a 11991.16% increase from fiscal 2024.
- Ovid Therapeutics Inc. net cash provided by (used in) financing activities for fiscal 2024 was $622.00K, a 97.96% decline from fiscal 2023.
- Ovid Therapeutics Inc. net cash provided by (used in) financing activities for fiscal 2023 was $30.54M, a 16802.10% increase from fiscal 2022.
- Ovid Therapeutics Inc. net cash provided by (used in) financing activities for fiscal 2022 was $180.66K, a 80.02% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $21.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $110.58M 10-Q · filed 2026-08-13 | $185.76M derived: sum of 3 quarters · filed 2026-08-13 | $185.78M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $88.98M 10-Q · filed 2026-05-12 | $164.16M derived: sum of 2 quarters · filed 2026-05-12 | $164.18M derived: sum of 3 quarters · filed 2026-05-12 | $164.18M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $75.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $75.19M derived: sum of 2 quarters · filed 2026-03-18 | $75.19M derived: sum of 3 quarters · filed 2026-08-13 | $75.21M 10-K · filed 2026-03-18 | ||||
| 2025-09-30 | $15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $15.00K derived: sum of 2 quarters · filed 2026-08-13 | $28.00K 10-Q · filed 2025-11-12 | $28.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $13.00K 10-Q · filed 2026-08-13 | $13.00K derived: sum of 3 quarters · filed 2026-08-13 | $51.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $13.00K 10-Q · filed 2026-05-12 | $13.00K derived: sum of 2 quarters · filed 2026-05-12 | $51.00K derived: sum of 3 quarters · filed 2026-05-12 | $407.00K derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $38.00K derived: sum of 2 quarters · filed 2026-03-18 | $394.00K derived: sum of 3 quarters · filed 2026-03-18 | $622.00K 10-K · filed 2026-03-18 | ||||
| 2024-09-30 | $38.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $394.00K derived: sum of 2 quarters · filed 2025-11-12 | $622.00K 10-Q · filed 2025-11-12 | $30.66M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $356.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $584.00K 10-Q · filed 2025-08-13 | $30.62M derived: sum of 3 quarters · filed 2025-08-13 | $30.84M derived: sum of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | $228.00K 10-Q · filed 2025-05-13 | $30.26M derived: sum of 2 quarters · filed 2025-05-13 | $30.48M derived: sum of 3 quarters · filed 2025-05-13 | $30.70M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | $30.03M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $30.26M derived: sum of 2 quarters · filed 2025-03-11 | $30.47M derived: sum of 3 quarters · filed 2025-03-11 | $30.54M 10-K · filed 2025-03-11 | $30.54M 10-K · filed 2024-03-08 | |||
| 2023-09-30 | $224.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $435.00K derived: sum of 2 quarters · filed 2024-11-12 | $502.00K 10-Q · filed 2024-11-12 | $501.81K 10-Q · filed 2023-11-03 | $458.40K derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | $211.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $278.00K 10-Q · filed 2024-08-13 | $278.09K 10-Q · filed 2023-08-04 | $234.40K derived: sum of 3 quarters · filed 2024-08-13 | $316.03K derived: sum of 4 quarters · filed 2024-08-13 | |||
| 2023-03-31 | $67.00K 10-Q · filed 2024-05-14 | $66.99K 10-Q · filed 2023-05-05 | $23.40K derived: sum of 2 quarters · filed 2024-05-14 | $105.03K derived: sum of 3 quarters · filed 2024-05-14 | $214.58K derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | -$43.60K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $38.03K derived: sum of 2 quarters · filed 2024-03-08 | $147.58K derived: sum of 3 quarters · filed 2024-03-08 | $180.66K 10-K · filed 2024-03-08 | ||||
| 2022-09-30 | $81.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $191.18K derived: sum of 2 quarters · filed 2023-11-03 | $224.26K 10-Q · filed 2023-11-03 | $333.44K derived: sum of 4 quarters · filed 2023-11-03 | ||||
| 2022-06-30 | $109.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $142.63K 10-Q · filed 2023-08-04 | $251.81K derived: sum of 3 quarters · filed 2023-08-04 | $800.86K derived: sum of 4 quarters · filed 2023-08-04 | ||||
| 2022-03-31 | $33.08K 10-Q · filed 2023-05-05 | $142.26K derived: sum of 2 quarters · filed 2023-05-05 | $691.31K derived: sum of 3 quarters · filed 2023-05-05 | $807.50K derived: sum of 4 quarters · filed 2023-05-05 | ||||
| 2021-12-31 | $109.18K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $658.23K derived: sum of 2 quarters · filed 2023-03-13 | $774.42K derived: sum of 3 quarters · filed 2023-03-13 | $904.08K 10-K · filed 2023-03-13 | ||||
| 2021-09-30 | $549.05K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $665.24K derived: sum of 2 quarters · filed 2022-11-08 | $794.90K 10-Q · filed 2022-11-08 | $562.42K derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | $116.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $245.85K 10-Q · filed 2022-08-09 | $13.37K derived: sum of 3 quarters · filed 2022-08-09 | $47.13M derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | $129.66K 10-Q · filed 2022-05-10 | -$102.82K derived: sum of 2 quarters · filed 2022-05-10 | $47.02M derived: sum of 3 quarters · filed 2022-05-10 | $47.19M derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | -$232.48K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $46.89M derived: sum of 2 quarters · filed 2022-03-15 | $47.06M derived: sum of 3 quarters · filed 2022-03-15 | $47.07M 10-K · filed 2022-03-15 | ||||
| 2020-09-30 | $47.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $47.29M derived: sum of 2 quarters · filed 2021-11-10 | $47.30M 10-Q · filed 2021-11-10 | $103.19M derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | $169.31K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $184.84K 10-Q · filed 2021-08-16 | $56.07M derived: sum of 3 quarters · filed 2021-08-16 | $56.13M derived: sum of 4 quarters · filed 2021-08-16 | ||||
| 2020-03-31 | $15.54K 10-Q · filed 2021-05-13 | $55.90M derived: sum of 2 quarters · filed 2021-05-13 | $55.96M derived: sum of 3 quarters · filed 2021-05-13 | $55.57M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $55.89M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $55.95M derived: sum of 2 quarters · filed 2021-03-15 | $55.55M derived: sum of 3 quarters · filed 2021-03-15 | $86.54M 10-K · filed 2021-03-15 | ||||
| 2019-09-30 | $58.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | -$333.09K derived: sum of 2 quarters · filed 2020-11-13 | $30.65M 10-Q · filed 2020-11-13 | $30.65M derived: sum of 4 quarters · filed 2020-11-13 | ||||
| 2019-06-30 | -$391.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $30.59M 10-Q · filed 2020-08-10 | $30.59M derived: sum of 3 quarters · filed 2020-08-10 | $30.71M derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | $30.99M 10-Q · filed 2020-05-07 | $30.99M derived: sum of 2 quarters · filed 2020-05-07 | $31.10M derived: sum of 3 quarters · filed 2020-05-07 | $31.20M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | $2.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $112.04K derived: sum of 2 quarters · filed 2020-03-11 | $210.74K derived: sum of 3 quarters · filed 2020-03-11 | $286.14K 10-K · filed 2020-03-11 | ||||
| 2018-09-30 | $112.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $210.74K derived: sum of 2 quarters · filed 2019-11-08 | $286.14K 10-Q · filed 2019-11-08 | $313.18K derived: sum of 4 quarters · filed 2019-11-08 | ||||
| 2018-06-30 | $98.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $174.10K 10-Q · filed 2019-08-07 | $201.14K derived: sum of 3 quarters · filed 2019-08-07 | -$524.51K derived: sum of 4 quarters · filed 2019-08-07 | ||||
| 2018-03-31 | $75.40K 10-Q · filed 2019-05-07 | $102.44K derived: sum of 2 quarters · filed 2019-05-07 | -$623.21K derived: sum of 3 quarters · filed 2019-05-07 | |||||
| 2017-12-31 | $27.04K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | -$698.62K derived: sum of 2 quarters · filed 2019-03-07 | $66.70M 10-K · filed 2019-03-07 | |||||
| 2017-09-30 | -$725.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $66.68M 10-Q · filed 2018-11-08 | ||||||
| 2017-06-30 | $67.40M 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |